BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 25591934)

  • 1. Role of osteopontin in the regulation of human bladder cancer proliferation and migration in T24 cells.
    Xu ST; Guo C; Ding X; Fan WJ; Zhang FH; Xu WL; Ma YC
    Mol Med Rep; 2015 May; 11(5):3701-7. PubMed ID: 25591934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting MACC1 by RNA interference inhibits proliferation and invasion of bladder urothelial carcinoma in T24 cells.
    Xu ST; Ding X; Ni QF; Jin SJ
    Int J Clin Exp Pathol; 2015; 8(7):7937-44. PubMed ID: 26339359
    [TBL] [Abstract][Full Text] [Related]  

  • 3.  Effect of siRNA targeting EZH2 on cell viability and apoptosis of bladder cancer T24 cells.
    Wang HF; Yang H; Hu LB; Lei YH; Qin Y; Li J; Bi CW; Wang JS; Huo Q
    Genet Mol Res; 2014 Nov; 13(4):9939-50. PubMed ID: 25501205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of osteopontin downregulation on the growth of prostate cancer PC-3 cells.
    Zheng J; Hou ZB; Jiao NL
    Mol Med Rep; 2011; 4(6):1225-31. PubMed ID: 21842122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of short-hairpin RNA expression vector-mediated osteopontin RNA interference on proliferation and invasion of prostate cancer PC-3 cells].
    Liu H; Chen AM; Guo FJ; Liao H; Hu WH; Xie J
    Chin J Cancer; 2010 Jan; 29(1):43-51. PubMed ID: 20038310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of osteopontin expression by RNA interference affects cell proliferation and chemotherapy sensitivity of breast cancer MDA-MB-231 cells.
    Yang L; Wei L; Zhao W; Wang X; Zheng G; Zheng M; Song X; Zuo W
    Mol Med Rep; 2012 Feb; 5(2):373-6. PubMed ID: 22143930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential of osteopontin as a therapeutic target for human colorectal cancer.
    Likui W; Hong W; Shuwen Z; Yuangang Y; Yan W
    J Gastrointest Surg; 2011 Apr; 15(4):652-9. PubMed ID: 21318445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A small interfering RNA targeting osteopontin as gastric cancer therapeutics.
    Gong M; Lu Z; Fang G; Bi J; Xue X
    Cancer Lett; 2008 Dec; 272(1):148-59. PubMed ID: 18694621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteopontin accelerates the development and metastasis of bladder cancer via activating JAK1/STAT1 pathway.
    Zhang N; Li F; Gao J; Zhang S; Wang Q
    Genes Genomics; 2020 Apr; 42(4):467-475. PubMed ID: 32088853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A short-hairpin RNA targeting osteopontin downregulates MMP-2 and MMP-9 expressions in prostate cancer PC-3 cells.
    Liu H; Chen A; Guo F; Yuan L
    Cancer Lett; 2010 Sep; 295(1):27-37. PubMed ID: 20207476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA interference-mediated vascular endothelial growth factor-C reduction suppresses malignant progression and enhances mitomycin C sensitivity of bladder cancer T24 cells.
    Zhang HH; Qi F; Shi YR; Miao JG; Zhou M; He W; Chen MF; Li Y; Zu XB; Qi L
    Cancer Biother Radiopharm; 2012 Jun; 27(5):291-8. PubMed ID: 21902544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inducing cell proliferation inhibition, apoptosis, and motility reduction by silencing long noncoding ribonucleic acid metastasis-associated lung adenocarcinoma transcript 1 in urothelial carcinoma of the bladder.
    Han Y; Liu Y; Nie L; Gui Y; Cai Z
    Urology; 2013 Jan; 81(1):209.e1-7. PubMed ID: 23153939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteopontin regulates growth and migration of human nasopharyngeal cancer cells.
    Yang G; Zhang Y; Wu J; Xiong J; Deng H; Wang J; Yang C; Zhu Z
    Mol Med Rep; 2011; 4(6):1169-73. PubMed ID: 21785824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Med19 in bladder cancer tissues and its role on bladder cancer cell growth.
    Zhang H; Jiang H; Wang W; Gong J; Zhang L; Chen Z; Ding Q
    Urol Oncol; 2012; 30(6):920-7. PubMed ID: 21478038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lentiviral-mediated siRNA targeted against osteopontin suppresses the growth and metastasis of gastric cancer cells.
    Wang ZM; Cui YH; Li W; Chen SY; Liu TS
    Oncol Rep; 2011 Apr; 25(4):997-1003. PubMed ID: 21286666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silencing of osteopontin promotes the radiosensitivity of breast cancer cells by reducing the expression of hypoxia inducible factor 1 and vascular endothelial growth factor.
    Yang L; Zhao W; Zuo WS; Wei L; Song XR; Wang XW; Zheng G; Zheng MZ
    Chin Med J (Engl); 2012 Jan; 125(2):293-9. PubMed ID: 22340562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of RUNX3 increases osteopontin expression and promotes cell migration in gastric cancer.
    Cheng HC; Liu YP; Shan YS; Huang CY; Lin FC; Lin LC; Lee L; Tsai CH; Hsiao M; Lu PJ
    Carcinogenesis; 2013 Nov; 34(11):2452-9. PubMed ID: 23774402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Knocking down osteopontin expression by specific siRNA reduces the in vitro invasiveness of human hepatocellular carcinoma cells].
    Zhu XQ; Ye QH; Lei KF; Chen J; Qin LX
    Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):404-7. PubMed ID: 17152482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of phospholipase C-epsilon by short-hairpin RNA-mediated gene silencing induces apoptosis in human bladder cancer cell lines.
    Zhang Y; Yan L; Zhao Y; Ou L; Wu X; Luo C
    Cancer Biother Radiopharm; 2013 Apr; 28(3):233-9. PubMed ID: 23484808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and Functions of Formyl Peptide Receptor 1 in Drug-Resistant Bladder Cancer.
    Jiang X; Lei T; Zhang M
    Technol Cancer Res Treat; 2018 Jan; 17():1533034618769413. PubMed ID: 29665744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.